Related Experiment Videos
Clinical Presentation and Diagnostic Patterns of Multisystem Inflammatory Syndrome in Children in a Pediatric
Alexander B Rosiejka1, Danny G Thomas2, Mark Nimmer2
1Medical College of Wisconsin, Milwaukee, Wisconsin, arosiejka@mcw.edu.
Insights
Multisystem inflammatory syndrome in children (MIS-C) diagnosis is challenging. Older children with cardiac and gastrointestinal symptoms are more likely to have MIS-C, while non-COVID-19 viral tests suggest alternative diagnoses.
Area of Science:
- Pediatric Emergency Medicine
- Infectious Diseases
- Critical Care
Background:
- Multisystem inflammatory syndrome in children (MIS-C) is a severe postinfectious complication of COVID-19.
- Diagnosis of MIS-C is challenging due to overlapping symptoms with other pediatric illnesses.
- Effective diagnostic strategies are needed for timely MIS-C identification in emergency departments.
Purpose of the Study:
- To describe emergency department (ED) evaluations for suspected MIS-C in children.
- To identify clinical and laboratory factors that differentiate MIS-C from alternative diagnoses.
- To aid clinicians in risk stratification and diagnostic decision-making for suspected MIS-C.
Main Methods:
- Retrospective study of children evaluated for MIS-C in a pediatric ED from July 2020 to December 2022.
- Comparison of clinical and laboratory characteristics between MIS-C and alternative diagnoses.
- Logistic regression analysis to identify factors associated with MIS-C.
Main Results:
- Of 792 children evaluated, 86 (11%) were diagnosed with MIS-C.
- Children with MIS-C were older (median age 7.4 vs 2.9 years) and had higher odds of cardiac, mucocutaneous, gastrointestinal, and hematologic system involvement.
- Positive non-COVID-19 viral tests were associated with alternative diagnoses (OR, 0.12).
Conclusions:
- Specific symptoms aligning with MIS-C criteria increase the likelihood of MIS-C diagnosis.
- Positive non-COVID-19 viral tests in children evaluated for MIS-C suggest alternative diagnoses.
- Findings can assist emergency department clinicians in diagnosing MIS-C and stratifying patient risk.
Introduction:
Multisystem inflammatory syndrome in children (MIS-C) is a severe postinfectious complication of COVID-19, and diagnosis remains challenging because of overlapping features with other illnesses. We sought to describe emergency department (ED) evaluations of children with suspected MIS-C at a southeast Wisconsin pediatric referral center and to identify factors that distinguish MIS-C from alternative diagnoses.
Methods:
This retrospective study included children evaluated for MIS-C in the Children's Wisconsin ED from July 2020 through December 2022. We compared clinical and laboratory characteristics of children diagnosed with MIS-C with those of children with alternative diagnoses and used logistic regression to identify factors associated with MIS-C.
Results:
Among 792 children evaluated, 86 (11%) were diagnosed with MIS-C; case counts declined over time. Children with MIS-C were older (median age, 7.4 vs 2.9 years; P < .001) and had greater odds of cardiac (OR, 50.4; 95% CI, 27.4-96.4), mucocutaneous (OR, 3.57; 95% CI, 2.18-6.04), gastrointestinal (OR, 2.36; 95% CI, 1.36-4.36), and hematologic (OR, 8.81; 95% CI, 5.41-14.4) system involvement than children with other diagnoses. Odds of MIS-C were reduced among children with a positive non-COVID-19 viral test (OR, 0.12; 95% CI, 0.02-0.41), but alternative diagnoses made before the ED visit were not associated with MIS-C risk.
Conclusions:
In this cohort of children evaluated for MIS-C in southeast Wisconsin, specific symptoms aligned with MIS-C diagnostic criteria were associated with increased odds of MIS-C, whereas positive non-COVID-19 viral tests were associated with alternative diagnoses. These findings may assist clinicians in risk stratification and diagnostic decision-making for children with suspected MIS-C in the emergency department setting.
Related Concept Videos
Myocarditis II: Clinical Features and Diagnostic Tests
Rocky Mountain Spotted Fever
Inflammatory Bowel Disease IV: Clinical Manifestations
Endocarditis II: Clinical Features of Infective Endocarditis
Multiple Sclerosis l: Introduction
Asthma III: Clinical Manifestations